Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110577974B reveals a green enzymatic route for high-purity chiral tetrahydropyridines, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN102249998A reveals a high-yield synthesis route for Cisatracurium Besylate, offering superior purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN109020788A reveals efficient inclusion resolution. High purity spiro indan diol derivatives for scalable chiral catalyst manufacturing.
Novel enzymatic route for Finerenone intermediates reduces heavy metal risk and cost significantly. Ideal for reliable pharmaceutical intermediate supplier partnerships seeking green chemistry.
Patent CN108586517A details a cost-effective 4-AA synthesis route offering supply chain stability and high purity for global pharmaceutical manufacturing partners.
Discover the novel synthesis of 4-AA antibiotic intermediate via patent CN108586517A. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable routes.
Advanced crystallization-induced dynamic resolution for antiviral nucleotide analogs. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115850115B reveals high-purity Ruxolitinib intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Advanced purification process for tenofovir prodrug ensuring high purity. Cost-effective supply chain solutions for pharmaceutical intermediates. Reliable manufacturing partner for global pharmaceutical companies seeking scalable synthesis routes.
Novel chiral resolution method enhances purity and yield for pharmaceutical intermediates. Optimized route ensures cost reduction and supply chain reliability for global buyers.
Patent CN118086121A reveals efficient biocatalytic route for R-Metalaxyl intermediate. Enhances purity and supply chain stability for global agrochemical manufacturers.
Patent CN102533888B enables continuous enzymatic production of high-purity L-tert-leucine. Reduces costs and ensures supply chain reliability for API manufacturing.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel dynamic kinetic resolution method for R-2-naphthylethylamine. High yield, 99% ee. Cost-effective nickel catalyst. Reliable supply chain partner.
Advanced process for D-tyrosine production using tartrate resolution. Offers superior cost efficiency and scalability for pharmaceutical intermediate manufacturing compared to enzymatic methods.
Patent CN104152525A reveals dynamic kinetic resolution for R-1-phenylethylamine. Achieve high yield and purity with cost-effective Raney nickel catalysts for supply chain stability.
Patent CN113201516A details a novel P-nitrobenzyl esterase mutant for solvent-free L-menthol production, offering superior stereoselectivity and cost-effective manufacturing.
Patent CN102399139B details a scalable resolution method for Shikonin and Alkannin. Achieve >99% ee with cost-effective raw materials for API manufacturing.
Patent CN104178546A details high-yield enzymatic resolution for S-1-naphthylethylamine. Offers superior purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104178547B analysis reveals enzymatic resolution for high purity. Supply chain advantages and cost reduction in pharmaceutical intermediates manufacturing.